The success of Sildenafil initially fueled a period of growth for pharma, nevertheless recent changes present a uncertain scenario for those considering a stake. Generic versions are eating into revenue, and continued https://jimisef454638.idblogmaker.com/39942615/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-play